Get ready for 2-in-1 Covid and flu jabs after new combined Moderna vaccine trial shows its better than single shots Patients may only need the one jab for protection against both illnesses by 2025 READ MORE: Cancer patients start getting tailored vaccines on the NHS By Kate Pickles Health Editor For The Daily Mail Published: 17:24 BST, 10 June 2024 | Updated: 20:09 BST, 10 June 2024 e-mail 44 shares 160 View comments Patients could soon be given two-in-one flu and Covid jabs after trials found it was just as effective as single shots. The combined vaccine from Moderna was found to provoke a higher immune response than separate single jabs, according to new data from the firm. The NHS currently uses Moderna's Spikevax vaccine alongside Pfizer /BioNTech's Comirnaty for Covid-19 for its booster programmes.
But a newer version of Spikevax has been created and tested by Moderna, which includes a dose of flu vaccine. Experts predict these combination jabs could see patients only needing one jab for protection against both illnesses as soon as 2025, with equivalents being developed by competitors Pfizer and BioNTech. Experts predict these combination jabs could see patients only needing one jab for protection against both illnesses as soon as 2025 The findings from Moderna showed that the mRNA-1083 vaccine met its goals and led to higher immune responses against flu and Covid than other single vaccines currently in use, including the current Spikevax.
It is the first time final phas.
